Skip to content
Robots, Ranked.

Are you a robotics manufacturer?

Claim your page to correct your specs and keep your listing current.

1,355companies listed

PROCEPT BioRobotics

United StatesFounded 2014
Ask Scout

PROCEPT BioRobotics is a robotics company founded 2014, based in United States, developing 2 robots primarily in the Surgical / Medical category.

CAPITAL & EVIDENCE

PROCEPT BioRobotics has raised US$245.0M across 3 confirmed rounds and has 2 cited customers but no deployment on record.

Raised

US$245.0M

across 3 confirmed rounds · latest Jun 2021 · Series G

Confirmed rounds recorded from January 2017. Every amount links to its source.

Correct this →

Shipped

2customers cited

named in public sources · no deployment on record

A deployment is recorded when a public source names both the customer and the robot, or the maker confirms it. Nothing here counts against PROCEPT BioRobotics.

In Surgical / Medical, CMR Surgical, BD Rowa and Catalia Health have deployment evidence on file.

Add a deployment →

Advanced robotic treatments empowering men's health with cutting-edge precision for BPH and prostate care.

PROCEPT BioRobotics develops the HYDROS Robotic System, an AI-powered platform for Aquablation therapy to treat benign prostatic hyperplasia (BPH). The system uses real-time ultrasound guidance and a heat-free waterjet for robotic-assisted, heat-free prostate treatment. Hospitals and ambulatory surgery centers in the US and internationally purchase the system. Key differentiators include AI-enabled automation, preservation of sexual function and continence, and efficacy across all prostate shapes and sizes.

Company facts

HQ
Redwood City, United States
Founded
2014 · 12 yrs
Employees
250

RoboScore

Products 45%58Range 30%43Activity53Attention84Readiness55Traction 25%73
59.40RoboIndexAll-rounder

57.42 RoboScore + 1.98 Momentum· Strong evidence

Products, Range, Traction set the number — the three factors present for every company. Activity, Attention, Readiness describe the brand but never move it. A value we don't have reads , never zero. Momentum is independently collected news coverage, worth at most 15 points and never a deduction — a maker we have heard nothing about keeps its full RoboScore. Claiming or paying moves nothing.

6 of 6 factors known. How it's calculated

Milestones

  1. PROCEPT BioRobotics announces international launch of the HYDROS Robotic System.

  2. St. Luke's Hospital acquires the HYDROS Robotic System for Aquablation therapy.

Press coverage

In the news

4 events

+1.98momentumof 15 max

Procept BioRobotics: Filling Robots Slower Than Placing Them (NASDAQ:PRCT)

Why PROCEPT BioRobotics has been in the news, across 3 outlets — collected and classified independently, so a maker cannot add to it. It never changes a robot's RoboScore — the evidence half of the RoboIndex — and it can move a robot up a board by at most 15 points.

Active products by PROCEPT BioRobotics

2 shown

Where will these robots operate? Often the same as your country — add more for multi-country deployments.

Your request goes to PROCEPT BioRobotics.

Surgical / Medical buying guides

Industry Knowledge →